Compositions and methods for anti-staphylococcal biologic agents
US10781246B2 · kind B2 · utility
2Cited by
3References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 4, 2016 |
| Grant date | Sep 22, 2020 |
| Priority date | — |
| Expiry date | Jun 4, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to staphylococcal leukotoxin and hemolysin binding molecules and fusion constructs. The present disclosure is further directed to methods of treating, preventing, and diagnosing staphylococcal infection in a subject using the binding molecules and fusion constructs described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.